DE69902131T2 - Kosmetische und/oder dermatologische Zusammensetzung, die Salicylsäure oder ein Salicylsäurederivat enthält, und ihre Verwendung - Google Patents

Kosmetische und/oder dermatologische Zusammensetzung, die Salicylsäure oder ein Salicylsäurederivat enthält, und ihre Verwendung

Info

Publication number
DE69902131T2
DE69902131T2 DE69902131T DE69902131T DE69902131T2 DE 69902131 T2 DE69902131 T2 DE 69902131T2 DE 69902131 T DE69902131 T DE 69902131T DE 69902131 T DE69902131 T DE 69902131T DE 69902131 T2 DE69902131 T2 DE 69902131T2
Authority
DE
Germany
Prior art keywords
salicylic acid
cosmetic
composition containing
dermatological composition
acid derivative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69902131T
Other languages
English (en)
Other versions
DE69902131D1 (de
Inventor
Philippe Touzan
Patricia Delambre
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LOreal SA
Original Assignee
LOreal SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LOreal SA filed Critical LOreal SA
Application granted granted Critical
Publication of DE69902131D1 publication Critical patent/DE69902131D1/de
Publication of DE69902131T2 publication Critical patent/DE69902131T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/06—Emulsions
    • A61K8/062—Oil-in-water emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/368—Carboxylic acids; Salts or anhydrides thereof with carboxyl groups directly bound to carbon atoms of aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A61K8/602—Glycosides, e.g. rutin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A61K8/608—Derivatives containing from 2 to 10 oxyalkylene groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/8141—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
    • A61K8/8158—Homopolymers or copolymers of amides or imides, e.g. (meth) acrylamide; Compositions of derivatives of such polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
    • A61K2800/28—Rubbing or scrubbing compositions; Peeling or abrasive compositions; Containing exfoliants
DE69902131T 1998-08-17 1999-07-09 Kosmetische und/oder dermatologische Zusammensetzung, die Salicylsäure oder ein Salicylsäurederivat enthält, und ihre Verwendung Expired - Lifetime DE69902131T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9810472A FR2782269B1 (fr) 1998-08-17 1998-08-17 Composition cosmetique et/ou dermatologique contenant de l'acide salicylique ou un derive d'acide salicylique et son utilisation

Publications (2)

Publication Number Publication Date
DE69902131D1 DE69902131D1 (de) 2002-08-22
DE69902131T2 true DE69902131T2 (de) 2002-11-07

Family

ID=9529717

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69902131T Expired - Lifetime DE69902131T2 (de) 1998-08-17 1999-07-09 Kosmetische und/oder dermatologische Zusammensetzung, die Salicylsäure oder ein Salicylsäurederivat enthält, und ihre Verwendung

Country Status (11)

Country Link
US (1) US6281203B1 (de)
EP (1) EP0987011B1 (de)
JP (1) JP3595206B2 (de)
KR (1) KR100350252B1 (de)
CN (1) CN1101180C (de)
AT (1) ATE220536T1 (de)
BR (1) BR9903434A (de)
CA (1) CA2279722C (de)
DE (1) DE69902131T2 (de)
ES (1) ES2181376T3 (de)
FR (1) FR2782269B1 (de)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19919481A1 (de) * 1999-04-29 2000-11-02 Beiersdorf Ag Stabile, gegen unreine Haut und gegen Akne wirksame Wirkstoffkombinationen mit einem Gehalt an grenzflächenaktiven Glucosederivaten und Hydroxycarbonsäuren
DE19956606A1 (de) * 1999-11-25 2001-05-31 Cognis Deutschland Gmbh Verwendung von Alkyl- und/oder Alkenyloligoglykosid-Fettsäureestern zur Verbesserung der sensorischen Beurteilung von Emulsionen
FR2810543A1 (fr) * 2000-06-26 2001-12-28 Oreal Composition cosmetique ou pharmaceutique comprenant un ester de dextrine et un gelifiant hydrophile
TWI249519B (en) 2000-08-29 2006-02-21 Nobex Corp Immunoregulatory compounds and derivatives and methods of treating diseases therewith
US8048924B2 (en) 2001-08-29 2011-11-01 Biocon Limited Methods and compositions employing 4-aminophenylacetic acid compounds
US7128903B2 (en) * 2001-10-03 2006-10-31 Innovative Pharmaceutical Concepts (Ipc) Inc. Pharmaceutical preparations useful for treating tumors and lesions of the skin and the mucous membranes and methods and kits using same
KR20030079231A (ko) * 2002-04-02 2003-10-10 지앤비코스메틱 피부 표면에 국소 적용되는, 피부 여드름 개선용 화장료조성물 및 그의 제조방법
US7214391B2 (en) * 2003-06-30 2007-05-08 Usana Health Sciences, Inc. Botanical extract compositions and process for preparing same
US20050136015A1 (en) * 2003-12-17 2005-06-23 McKie Derrick B. Topical use of halosalicylic acid derivatives
FR2864784B1 (fr) * 2004-01-06 2006-02-10 Oreal Composition cosmetique comprenant un organopolysiloxane elastomere et un compose amino-sulfonique
ES2315119B1 (es) * 2006-08-16 2009-12-30 Action Medicines, S.L. Uso de derivados 2,5 -dihidroxibencenicos en la fabricacion de medicamentos y cosmeticos.
US20080125485A1 (en) * 2004-02-17 2008-05-29 Action Medicines Use of 2,5-Dihydroxybenzene Derivatives for Treating Actinic Keratosis
US20070149618A1 (en) * 2004-02-17 2007-06-28 Action Medicines, S.L. Methods of use for 2,5-dihydroxybenzene sulfonic acid compounds for the treatment of cancer, rosacea and psoriasis
ES2238924B1 (es) * 2004-02-17 2006-12-01 Investread Europa, S.L. Uso del acido 2,5-dihidroxibencenosulfonico, en la fabricacion de medicamentos de aplicacion en el tratamiento de enfermedades angiodependientes.
HUE028158T2 (en) 2004-07-07 2016-12-28 Biocon Ltd Synthesis of bound immunoregulatory compounds
US20070025947A1 (en) * 2005-07-29 2007-02-01 L'oreal Anti-acne method and kit
EP2056815B1 (de) 2006-08-16 2013-03-20 Amderma Pharmaceuticals, Llc Verwendung von 2,5-dihydroxybenzol-derivaten zur behandlung von dermatitis
ES2315118B1 (es) * 2006-08-16 2009-12-30 Action Medicines, S.L. Uso de los compuestos y derivados 2,5-dihidroxibencenicos en la preparacion de medicamentos utiles en el tratamiento de rosacea y psoriasis.
WO2008020028A1 (en) 2006-08-16 2008-02-21 Action Medicines, S.L. 2,5 dihydroxybenzene compounds for the treatment of rosacea
AU2008353441A1 (en) * 2008-03-28 2009-10-01 Nox Technologies, Inc. Compositions comprising arnox-inhibitors for the inhibition of reactive oxygen species
US9676696B2 (en) 2009-01-29 2017-06-13 The Procter & Gamble Company Regulation of mammalian keratinous tissue using skin and/or hair care actives
FR2988291B1 (fr) * 2012-03-23 2014-03-21 Oreal Composition cosmetique comprenant un compose d'acide cucurbique, un ester de sucre polyoxyalkylene et un polymere acrylique semicristallin
EP2861204B1 (de) * 2012-06-15 2016-08-31 Lubrizol Advanced Materials, Inc. Alkylglycosidbasierte mizellare verdickungsmittel für tensidsysteme
US10307346B2 (en) 2013-07-15 2019-06-04 The Procter & Gamble Company Applied films for smoothing wrinkles and skin texture imperfections
EP3024431A1 (de) * 2013-07-22 2016-06-01 The Procter & Gamble Company Stabile hautpflegezusammensetzungen mit hohem salzgehalt
JP5760280B1 (ja) * 2014-05-12 2015-08-05 株式会社東洋新薬 発泡性皮膚外用剤
US20160175222A1 (en) * 2014-12-17 2016-06-23 L'oreal Waterproof mascara composition
KR102463237B1 (ko) * 2015-12-24 2022-11-04 (주)아모레퍼시픽 살리실산 유도체와 그 제조방법 및 이를 함유하는 미백용 화장료 조성물
EA201991699A1 (ru) 2017-02-16 2020-01-21 Кареджен Ко., Лтд. Конъюгат салициловой кислоты и пептида
KR102016658B1 (ko) 2017-02-16 2019-08-30 (주)케어젠 살리실산과 펩타이드의 결합체
US10660838B2 (en) 2017-06-23 2020-05-26 The Procter & Gamble Company Composition and method for improving the appearance of skin
CN111031794B (zh) * 2017-06-30 2021-12-14 莱雅公司 含有4-(3-乙氧基-4-羟苯基)丁-2-酮和有机酸化合物的抗微生物混合物、以及含有该抗微生物混合物的化妆品组合物
KR102496117B1 (ko) * 2017-11-28 2023-02-06 (주)아모레퍼시픽 겔상 화장료 조성물
CN112437657A (zh) 2018-07-03 2021-03-02 宝洁公司 处理皮肤状况的方法
KR102334446B1 (ko) * 2020-02-07 2021-12-03 코스맥스 주식회사 투명 세정용 화장료 조성물
EP4157206A1 (de) 2020-06-01 2023-04-05 The Procter & Gamble Company Verfahren zur verbesserung der penetration einer vitamin-b3-verbindung in die haut
US10959933B1 (en) 2020-06-01 2021-03-30 The Procter & Gamble Company Low pH skin care composition and methods of using the same
JP2023536047A (ja) * 2020-07-31 2023-08-23 ロレアル ケラチン物質をケアするためのスフィンゴモナス（Ｓｐｈｉｎｇｏｍｏｎａｓ）発酵物抽出物を含む組成物

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4720353A (en) * 1987-04-14 1988-01-19 Richardson-Vicks Inc. Stable pharmaceutical w/o emulsion composition
LU87408A1 (fr) * 1988-12-16 1990-07-10 Oreal Utilisation de derives salicyles pour le traitement du vieillissement de la peau
FR2709982B1 (fr) * 1993-09-15 1995-12-08 Oreal Emulsions acides stables de type huile-dans-eau et compositions les contenant.
US5653970A (en) * 1994-12-08 1997-08-05 Lever Brothers Company, Division Of Conopco, Inc. Personal product compositions comprising heteroatom containing alkyl aldonamide compounds
FR2732594B1 (fr) * 1995-04-07 1997-06-06 Oreal Utilisation de derives d'acide salicylique pour la depigmentation de la peau
US5665364A (en) * 1995-07-24 1997-09-09 The Procter & Gamble Company Compositions for topical delivery of active ingredients
WO1997044049A1 (en) * 1996-05-17 1997-11-27 The Procter & Gamble Company Cosmetic compositions
CN1226820A (zh) * 1996-06-27 1999-08-25 普罗克特和甘保尔公司 化妆品组合物
FR2755366B1 (fr) * 1996-11-04 1998-12-04 Oreal Composition rincable pour le soin de la peau
SE520645C2 (sv) * 1996-11-15 2003-08-05 Interhealth Ab Terapeutiska och kosmetiska kompositioner, deras användning och metod för framställning därav

Also Published As

Publication number Publication date
FR2782269B1 (fr) 2001-08-31
CA2279722A1 (fr) 2000-02-17
ES2181376T3 (es) 2003-02-16
EP0987011A1 (de) 2000-03-22
EP0987011B1 (de) 2002-07-17
DE69902131D1 (de) 2002-08-22
CN1245054A (zh) 2000-02-23
ATE220536T1 (de) 2002-08-15
KR100350252B1 (ko) 2002-08-24
KR20000017297A (ko) 2000-03-25
CA2279722C (fr) 2004-10-05
JP3595206B2 (ja) 2004-12-02
CN1101180C (zh) 2003-02-12
BR9903434A (pt) 2000-09-26
FR2782269A1 (fr) 2000-02-18
JP2000063263A (ja) 2000-02-29
US6281203B1 (en) 2001-08-28

Similar Documents

Publication Publication Date Title
DE69902131T2 (de) Kosmetische und/oder dermatologische Zusammensetzung, die Salicylsäure oder ein Salicylsäurederivat enthält, und ihre Verwendung
DE3850109T2 (de) 13-trans-retinsäureester.
ES2091108T3 (es) Composiciones cosmeticas y dermatologicas que asocian ceramidas y acido linoleico, y su preparacion.
ATE294589T1 (de) Fett(öl)haltiges mittel, enthaltend zwiebelextrakt, seine herstellung und seine verwendung zur pflege, vorbeugung oder behandlung von geschädigtem hautgewebe, insbesondere von narben
ATE237303T1 (de) Verwendung von zusammensetzungen mit benzoylperoxyd, glycolsäure und zink zur behandlung von dermatologischen krankheiten
DE69312942T2 (de) Kosmetische oder dermatologische zusammensetzung, die mindestens ein saponin vomginsenosid-typ enthält, zur haarpflege
ATE530179T1 (de) Verwendung von kreatin und/oder kreatinderivaten in dermatologischen zubereitungen
DE69716251D1 (de) Verwendung von oktoxyglyzerin in einer kosmetische und/oder dermatologische zusammensetzung zur behandlung von seborrhea und akne
DE69315927T2 (de) Kosmetische Zusammensetzung, die einen Lipidstoff und eine Hydroxy - oder Ketofettsäure enthält
DE69503179D1 (de) Kosmetische und/oder dermatologische Zusammensetzung, die ein Tri (alpha-hydroxyacylat) von glycerin als einzigen Glycerinprecursor enthält
DE69108256D1 (de) Anwendug der saponine von medicago für die herstellung von kosmetischen oder pharmazeutischen namentlich dermatologischen zusammensetzungen welche die erneuerung der epidermis fördern,das wiederwachstum der haare stimulieren oder ihren ausfall verzögern.
KR920700634A (ko) 좌창 또는 건선 피부병을 치료하는 방법 및 여기에 사용되는 조성물
DE69029100D1 (de) Verwendung von Ketoconazol und ein Retinoid zur Behandlung der Akne vulgaris
DE69631478D1 (de) Verwendung von vitamin d4-derivaten zur behandlung von hauterkrankungen
ATE160561T1 (de) L-carnitin-salz, dieses enthaltende kosmetische und pharmazeutische zusammensetzungen zur behandlung von dermatosen
DE69004046T2 (de) Kosmetische oder pharmazeutische Zusammensetzung zur topischen Verwendung die mindestens ein Retinoid-Derivat und mindestens ein Pyrimidin-Derivat enthält.
DK0700897T3 (da) L-carnitinsalt og kosmetiske og farmaceutiske præparater indeholdende samme til behandling af hudsygdomme
DE318369T1 (de) Zusammensetzung aus lipiden lamellaren hydratwasser enthaltenden phasen oder liposomen, die tyrosin oder ein tyrosinderivat enthalten und kosmetische oder pharmazeutische, insbesondere dermatologische zusammensetzung mit pigmentierender wirkung.
ATE102019T1 (de) Mittel zur kosmetischen oder pharmazeutischen verwendung.
ATE206052T1 (de) Verwendung von sphingosin-1-phosphat, sphingosin- 1-phosphat-derivaten und/oder deren gemische zur behandlung von entzündlichen hautkrankheiten
EP0968707A3 (de) Gegen Akne und entzündete Comedonen wirksame Zubereitungen enthaltend Serin-Proteasen und ein oder mehrere Calciumsalze
EP0744175A3 (de) Kosmetische oder dermatologische Zubereitungen mit einem Gehalt an alpha-Hydroxyfettsäuren
FI910308A0 (fi) Vattenloesliga vitamin a preparationer foer applicering pao huden.
ATE86611T1 (de) Topische vorstufen von arzneimitteln zur behandlung von akne und hautkrankheiten.
WO2000050047A3 (es) Composicion para el tratamiento de la psoriasis

Legal Events

Date Code Title Description
8364 No opposition during term of opposition